PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Sesquiterpenoid compound 5 from root bark exhibited potent anti-neuroinflammatory effects in LPS-induced BV-2 cells, exceeding the effectiveness of curcumin [PMID:40090561]
Kukoamine A from root bark ameliorated age-related decrease in swimming activity and preserved muscle mitochondrial morphology in C. elegans [PMID:40850658]
Lignanamides and glycosides from root bark exhibited potent antihyperlipidemic activities in HepG2 cells, reducing intracellular triglyceride and total cholesterol levels [PMID:29737867, 28890177]
A formula containing L. chinense (Osteo-F) improved arthritis scores, bone mineral content, and cartilage integrity in rat models [PMID:40357339]
Water extract of L. chinense roots increased secretion of pro-inflammatory cytokines (TNF-α, IL-6) and enhanced phagocytic activity of macrophages [PMID:32215941]
Evidence summary
PubMed sources
- 1.PMID: 32533890 (2020) — Fruit ripening in Lycium barbarum and Lycium ruthenicum is associated with distinct gene expression patterns. · FEBS open bio
- 2.PMID: 40090561 (2025) — Sesquiterpenoids isolated from the root bark of Lycium chinense. · Phytochemistry
- 3.PMID: 40850658 (2026) — Kukoamine A from the root bark of Lycium chinense Miller enhances mobility in an aged Caenorhabditis elegans model by regulating mitochondrial function through HSF-1-mediated upregulation of heat shock proteins. · Journal of ethnopharmacology
- 4.PMID: 36912477 (2023) — A comprehensive review on the ethnobotany, phytochemistry, pharmacology and quality control of the genus Lycium in China. · Food & function
- 5.PMID: 40357339 (2025)